Serotonin syndrome after single doses of co-amoxiclav during treatment with venlafaxine.
Connor
Henry
H
County Hospital, Hereford HR1 2ER, UK. henry.connor@hhtr.nhs.uk
D019980:Amoxicillin-Potassium Clavulanate Combination / Q000009:adverse effects*; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects*; D003511:Cyclohexanols / Q000009:adverse effects*; D004347:Drug Interactions; D004359:Drug Therapy, Combination / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D020230:Serotonin Syndrome / Q000209:etiology*; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects; D000069470:Venlafaxine Hydrochloride
D019980:Amoxicillin-Potassium Clavulanate Combination; D000900:Anti-Bacterial Agents; D018687:Antidepressive Agents, Second-Generation; D003511:Cyclohexanols; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride